ArticleCase reports in endocrinology2026
Non-Autoimmune Hyperthyroidism Associated With a Novel Germline Mutation (D633N) in the TSH Receptor.
Article in Case reports in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Non-Autoimmune Hyperthyroidism Associated With a Novel Germline Mutation (D633N) in the TSH Receptor.Case reports in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nonautoimmune hyperthyroidism resulting from an activating germline thyroid-stimulating hormone receptor (TSHR) gene mutation is a rare condition that often presents a diagnostic challenge. We report the case of a 75-year-old woman with a 20-year history of goiter and subclinical hyperthyroidism who presented with overt thyrotoxicosis. Laboratory tests confirmed hyperthyroidism with suppressed TSH, whereas thyrotropin receptor antibody (TRAb) and thyroid-stimulating antibody (TSAb) were negative, making it difficult to distinguish from toxic multinodular goiter. Initial management with potassium iodide was ineffective. Subsequent radioactive iodine (RI) therapy was complicated by severe destructive thyroiditis with worsening thyrotoxicosis and heart failure. Following hormonal control with methimazole (MMI) and dexamethasone, a total thyroidectomy was performed for definitive management, successfully normalizing thyroid function. Histopathology revealed an adenomatous goiter. Postoperative genetic analysis using peripheral blood DNA, prompted by the atypical clinical course, identified a novel heterozygous germline mutation in the TSHR gene: c.1897G > A (p.D633N). This case expands the spectrum of activating TSHR mutations causing nonautoimmune hyperthyroidism. Functional analysis demonstrated modest constitutive activity of the variant, which may explain the unusually late clinical onset. This report underscores the importance of considering nonautoimmune hyperthyroidism, including nonautoimmune hyperthyroidism, in patients with antibody-negative hyperthyroidism, even in elderly individuals without a known family history.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.